EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathies

Dorothea Böken, Melissa Huang, Yunzhao Wu, Emre Fertan, Matthew W Cotton, Georg Meisl, Jeff Y L Lam, Shaan Baig, James B Rowe, Colin Smith, Annelies Quaegebeur, Dezerae Cox und 2 weitere

Cell Reports · 2026

DOI: 10.1016/j.celrep.2026.116934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Dorothea Böken und 13 weiteren Autor:innen. Beteiligte Einrichtung: Yusuf Hamied Department of Chemistry, University of Cambridge, CB2 1EW Cambridge, UK; UK Dementia Research Institute, University of Cambridge, CB2 0A…. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies, Protein Aggregates, Protein Aggregation, Pathological. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Dementia Research Institute, NIHR Cambridge Biomedical Research Centre, Motor Neurone Disease Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tauopathies are neurodegenerative diseases marked by pathological tau aggregation. While disease-specific folds of insoluble tau filaments have been established, it remains unclear whether the smaller, earlier species also differ across tauopathies. Here, we characterize these small tau aggregates from postmortem brain of individuals with Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration, Pick's disease, and healthy controls. Using two complementary single-molecule assays, we confirm that small tau aggregates vary in abundance, morphology, and post-translational modifications. AD features specific long, fibrillar-shaped aggregates enriched in phospho-epitopes, while PSP aggregates are shorter, round, and selectively phosphorylated at serine 356, a site we identify as correlating with markers of inflammation and apoptosis. Aggregate properties co-vary with cellular stress signatures and align with disease-specific seeding profiles, suggesting distinct pathological mechanisms. These findings suggest that small tau aggregates are not a shared intermediate but instead encode disease-specific mechanisms, with potential as both biomarkers and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsTauopathiesProtein AggregatesProtein Aggregation, PathologicalHumansAlzheimer DiseasePhosphorylationSupranuclear Palsy, ProgressiveBrainFemalePick Disease of the BrainProtein Processing, Post-TranslationalCorticobasal DegenerationMale

Stichwörter der Autor:innen

Alzheimer’s diseaseCBDCP: NeurosciencePSPPick’s diseaseSimoasingle moleculesuper-resolution microscopytautau aggregatestauopathies

Substanzen

tau ProteinsProtein Aggregates

Autor:innen und Institutionen

  • Yusuf Hamied Department of Chemistry, University of Cambridge, CB2 1EW Cambridge, UK; UK Dementia Research Institute, University of Cambridge, CB2 0AH Cambridge, UK.
  • UK Dementia Research Institute, University of Cambridge, CB2 0AH Cambridge, UK.
  • Yusuf Hamied Department of Chemistry, University of Cambridge, CB2 1EW Cambridge, UK; UK Dementia Research Institute, University of Cambridge, CB2 0AH Cambridge, UK; Division of Life Science and State Key Laboratory of…
  • Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, CB2 0SZ Cambridge, UK.
  • Department of Neuropathology, University of Edinburgh, EH4 2XU Edinburgh, UK.
  • Yusuf Hamied Department of Chemistry, University of Cambridge, CB2 1EW Cambridge, UK; UK Dementia Research Institute, University of Cambridge, CB2 0AH Cambridge, UK; School of Sciences, University of Wollongong, Wollong…

Förderung

  • UK Dementia Research Institute
  • NIHR Cambridge Biomedical Research Centre
  • Motor Neurone Disease Association
  • Wellcome Trust
  • The Royal Society
  • Medical Research Council

Zitieren

APA

Böken, D., Huang, M., Wu, Y., Fertan, E., Cotton, M. W., Meisl, G., Lam, J. Y. L., Baig, S., Rowe, J. B., Smith, C., Quaegebeur, A., Cox, D., McEwan, W. A., & Klenerman, D. (2026). Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathies. Cell Reports. https://doi.org/10.1016/j.celrep.2026.116934

Vancouver

Böken D, Huang M, Wu Y, Fertan E, Cotton MW, Meisl G, et al. Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathies. Cell Reports. 2026. doi:10.1016/j.celrep.2026.116934

BibTeX
@article{Bken2026,
  author = {Böken, Dorothea and Huang, Melissa and Wu, Yunzhao and Fertan, Emre and Cotton, Matthew W and Meisl, Georg and Lam, Jeff Y L and Baig, Shaan and Rowe, James B and Smith, Colin and Quaegebeur, Annelies and Cox, Dezerae and McEwan, William A and Klenerman, David},
  title = {Nanoscopic tau aggregates are not shared intermediates but disease-specific entities across tauopathies},
  journal = {Cell Reports},
  year = {2026},
  doi = {10.1016/j.celrep.2026.116934}
}
Kostenlos starten →